Fleming T - Search Results

1

A phase II trial of recombinant tumor necrosis factor in patients with adenocarcinoma of the pancreas: a Southwest Oncology Group study.

Brown TD, Goodman P, Fleming T, Macdonald JS, Hersh EM, Braun TJ. Brown TD, et al. Among authors: fleming t. J Immunother (1991). 1991 Oct;10(5):376-8. doi: 10.1097/00002371-199110000-00010. J Immunother (1991). 1991. PMID: 1790146 Clinical Trial.

2

Phase II trial of recombinant DNA gamma-interferon in advanced colorectal cancer: a Southwest Oncology Group study.

Brown TD, Goodman PJ, Fleming T, Macdonald JS, O'Rourke T, Taylor SA, Neefe JR, Gaynor E. Brown TD, et al. Among authors: fleming t. J Immunother (1991). 1991 Oct;10(5):379-82. doi: 10.1097/00002371-199110000-00011. J Immunother (1991). 1991. PMID: 1790147 Clinical Trial.

3

A phase II trial of recombinant tumor necrosis factor in patients with metastatic colorectal adenocarcinoma: a Southwest Oncology Group study.

Whitehead RP, Fleming T, Macdonald JS, Goodman PJ, Neefe J, Braun TJ, Swinnen LJ, Hersh EM. Whitehead RP, et al. Among authors: fleming t. J Biol Response Mod. 1990 Dec;9(6):588-91. J Biol Response Mod. 1990. PMID: 2074444 Clinical Trial.

4

Phase II trial of amonafide in advanced colorectal cancer: a SouthWest Oncology Group study.

Brown TD, Goodman PJ, Fleming T, Macdonald JS, Craig JB, Einstein AB. Brown TD, et al. Among authors: fleming t. Anticancer Drugs. 1993 Feb;4(1):49-50. doi: 10.1097/00001813-199302000-00006. Anticancer Drugs. 1993. PMID: 8457714 Clinical Trial.

5

Phase II trial of trimetrexate in advanced esophageal cancer: a southwest oncology group study.

Fleming TR, Brown TD, Ross SW, Macdonald JS. Fleming TR, et al. Invest New Drugs. 1996;13(4):363-5. doi: 10.1007/BF00873146. Invest New Drugs. 1996. PMID: 8824358 Clinical Trial.

6

High incidence of coagualopathy in phase II studies of recombinant tumor necrosis factor in advanced pancreatic and gastric cancers.

Muggia FM, Brown TD, Goodman PJ, Macdonald JS, Hersh EM, Fleming TR, Leichman L. Muggia FM, et al. Among authors: fleming tr. Anticancer Drugs. 1992 Jun;3(3):211-7. doi: 10.1097/00001813-199206000-00002. Anticancer Drugs. 1992. PMID: 1525400 Clinical Trial.

7

Phase II trial of menogaril in adenocarcinoma of the pancreas. A Southwest Oncology Group study.

Brown TD, Goodman PJ, Fleming TR, Baker LH, Macdonald JS. Brown TD, et al. Among authors: fleming tr. Invest New Drugs. 1991 Feb;9(1):77-8. doi: 10.1007/BF00194550. Invest New Drugs. 1991. PMID: 1827433 Clinical Trial. No abstract available.

8

Phase II trial of echinomycin in advanced colorectal cancer. A Southwest Oncology Group study.

Brown TD, Goodman PJ, Fleming TR, Taylor SA, Macdonald JS. Brown TD, et al. Among authors: fleming tr. Invest New Drugs. 1991 Feb;9(1):113-4. doi: 10.1007/BF00194561. Invest New Drugs. 1991. PMID: 2026480 Clinical Trial. No abstract available.

9

Phase II evaluation of recombinant gamma-interferon in patients with advanced pancreatic carcinoma: a Southwest Oncology Group study.

Von Hoff DD, Fleming TR, Macdonald JS, Goodman PJ, Van Damme J, Brown TD, O'Rourke T, Feun LG, Keppen MD. Von Hoff DD, et al. Among authors: fleming tr. J Biol Response Mod. 1990 Dec;9(6):584-7. J Biol Response Mod. 1990. PMID: 2127424 Clinical Trial.

10

Phase II study of pibenzimol in pancreatic cancer. A Southwest Oncology Group study.

Kraut EH, Fleming T, Segal M, Neidhart JA, Behrens BC, MacDonald J. Kraut EH, et al. Among authors: fleming t. Invest New Drugs. 1991 Feb;9(1):95-6. doi: 10.1007/BF00194556. Invest New Drugs. 1991. PMID: 1709154 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,169 results

Search Page

Filters